TV News LIES

Wednesday, Jan 17th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Court battle brewing over work rules for Medicaid

Seema VermaA battle is brewing in the courts over the Trump administration's move to let states impose...

Florida House approves bill to help anti-abortion centers

House Speaker Richard CorcoranFlorida may agree to permanently fund anti-abortion pregnancy centers under a bill passed by the Republican-led...

Top anti-abortion advocate resigns at health department

anti abortion advocate Teresa Manning leaves HHS post after less than a yearA top anti-abortion advocate at the Department of Health and Human Services (HHS) abruptly resigned Friday...

Without warning, the government just ended a registry of mental illness and drug abuse programs

NREPP data base wiped out In a sudden move that took many industry stakeholders by surprise, the Trump administration last month...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!